Showing 35,225 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

PrEP science

Continuing declines in HIV diagnoses thanks to successful PrEP roll-out in New South Wales

Editor's pick
University of New South Wales
2 July 2021
Epidemiology & behaviour

Chemsex is top of the list of risk factors for HIV infection in gay and bisexual men in England

News
2 July 2021
Ethnic & cultural minorities

‘Invisible to the CDC’: Kevin Moseby, Ph.D., on the Whitewashed History of HIV/AIDS Research

Editor's pick
TheBodyPro
1 July 2021
Access to healthcare

Report shows big COVID-19-related HIV prevention programme service disruptions, but highlights that HIV service innovations and adaptations are possible

Editor's pick
UNAIDS
1 July 2021
HIV in the arts & media

The Instagram Account That Remembers the Human Story, and the Human Cost, of the HIV Crisis

Editor's pick
Esquire
1 July 2021
History of HIV & AIDS

UK AIDS Memorial Quilt Display Video

July 2021
Experiences of stigma

In Mexico, an HIV-Positive Man’s Death Sparks Protests for Reform

Editor's pick
TheBody
1 July 2021
Global health initiatives

Opinion: US leadership matters in fighting AIDS

Editor's pick
Devex
1 July 2021
Pharmaceutical industry

Gilead files long-acting HIV med for patients running out of options

Editor's pick
FierceBiotech
1 July 2021
Starting treatment

Starting HIV Treatment Is Personal, Not One-Size-Fits-All

Editor's pick
TheBody
1 July 2021
Access to healthcare

Kenya: Six-Month Standoff on ARVs Ends After Deal Struck

Editor's pick
AllAfrica
1 July 2021
Telling people you have HIV

HIV disclosure disrupts the lives of Black gay and bisexual men in Louisiana

News
30 June 2021
HIV treatment

Lamivudine Factsheet

About HIV
June 2021
Harm reduction

US: Helping Drug Users Survive, Not Abstain: ‘Harm Reduction’ Gains Federal Support

Editor's pick
New York Times
29 June 2021
Improving HIV care

HIV and COVID-19: Getting HIV Care Back on Track

Editor's pick
POZ
29 June 2021
Pharmaceutical industry

GSK puts long-acting injectables at heart of HIV growth plans, downplays threat of oral rival from Gilead and Merck

Editor's pick
FiercePharma
29 June 2021
Weight gain & lipodystrophy

Strategies for Managing Weight Gain in HIV Patients

Editor's pick
Infectious Disease Special Edition
29 June 2021
New & experimental HIV treatments

Gilead Submits New Drug Application to U.S. Food and Drug Administration for Lenacapavir, an Investigational, Long-Acting Capsid Inhibitor for the Treatment of HIV-1 in People With Limited Therapy Options

Editor's pick
Gilead press release
29 June 2021
HIV treatment

Efavirenz Factsheet

About HIV
June 2021
Activism & civil society

aidsmapCHAT: Pride 2021 special – series 4, episode 4 Video

June 2021

aidsmap news: HIV infection may become rare in UK gay men by 2030, researchers say, 28 June 2021

June 2021
HIV testing programmes & uptake

HIV Screening in the ER Can Speed Linkage to Care, but Is It Feasible?

Editor's pick
TheBodyPro
28 June 2021
HIV testing programmes & uptake

US: HIV Testing Rates Remain Low Despite CDC Recommendations

Editor's pick
American Journal of Managed Care
28 June 2021
HIV & criminal law

Lawyers must explain why they didn’t raise ‘obvious’ issue in appeal

Editor's pick
The Irish Times
28 June 2021